Latanoprost Completed Phase 2 Trials for Glaucoma, Primary Open Angle (POAG) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01494753Pharmacokinetics, Efficacy and Safety Assessment of T2345 Compared With Active Comparator in Newly Diagnosed Patients With Open-angle Glaucoma or Ocular Hypertension
NCT01887223Transconjunctival Needling Revision Versus Medical Treatment